Tripthi Kamath

2.7k total citations · 1 hit paper
22 papers, 2.0k citations indexed

About

Tripthi Kamath is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Physiology. According to data from OpenAlex, Tripthi Kamath has authored 22 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 6 papers in Physiology. Recurrent topics in Tripthi Kamath's work include Asthma and respiratory diseases (5 papers), Breast Cancer Treatment Studies (4 papers) and HER2/EGFR in Cancer Research (4 papers). Tripthi Kamath is often cited by papers focused on Asthma and respiratory diseases (5 papers), Breast Cancer Treatment Studies (4 papers) and HER2/EGFR in Cancer Research (4 papers). Tripthi Kamath collaborates with scholars based in United States, Switzerland and Italy. Tripthi Kamath's co-authors include Jose R. Pio, Stanley S. Franklin, G. Rhys Williams, Nathan D. Wong, Shaista Malik, Gilbert L’Italien, Sean D. Sullivan, Dave P. Miller, Michael K. Gould and Paul D. Blanc and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Journal of the American College of Cardiology.

In The Last Decade

Tripthi Kamath

21 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults

2004 1.4k citations Shaista Malik, Nathan D. Wong et al. Circulation profile →

Peers

Tripthi Kamath

EDM

CCM

PHYSI

EPIDE

PRM

Andrea Galassi Italy

LieLing Wu United States

Chi-Pang Wen Taiwan

Erik Ingelsson Sweden

A.R. Folsom United States

Henrik Scharling Denmark

Jose R. Pio United States

Kyung Eun Yun South Korea

Cihangir Erem Türkiye

Jiin Ahn South Korea

Andrea Galassi Italy

Tripthi Kamath

525 ×0.6

EDM

456 ×0.8

CCM

262 ×0.5

PHYSI

324 ×0.8

EPIDE

219 ×0.7

PRM

Citations per year, relative to Tripthi Kamath Tripthi Kamath (= 1×) peers Andrea Galassi

Countries citing papers authored by Tripthi Kamath

Since Specialization

Citations

This map shows the geographic impact of Tripthi Kamath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tripthi Kamath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tripthi Kamath more than expected).

Fields of papers citing papers by Tripthi Kamath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tripthi Kamath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tripthi Kamath. The network helps show where Tripthi Kamath may publish in the future.

Co-authorship network of co-authors of Tripthi Kamath

This figure shows the co-authorship network connecting the top 25 collaborators of Tripthi Kamath. A scholar is included among the top collaborators of Tripthi Kamath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tripthi Kamath. Tripthi Kamath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kamath, Tripthi, Ernst Eber, Christian Lupinek, et al.. (2025). Convergent monoclonal IgE antibodies from peanut allergic patients are multispecific to immunodominant epitopes of unrelated major peanut and tree nut allergens. Allergology International. 74(4). 622–632.

Polinski, Jennifer M., Andrew R. Weckstein, Michael Batech, et al.. (2022). Durability of the Single-Dose Ad26.COV2.S Vaccine in the Prevention of COVID-19 Infections and Hospitalizations in the US Before and During the Delta Variant Surge. JAMA Network Open. 5(3). e222959–e222959. 37 indexed citations

Cottin, Vincent, Paolo Spagnolo, Philippe Bonniaud, et al.. (2021). Mortality and Respiratory-Related Hospitalizations in Idiopathic Pulmonary Fibrosis Not Treated With Antifibrotics. Frontiers in Medicine. 8. 802989–802989. 8 indexed citations

Bonniaud, Philippe, Vincent Cottin, Paolo Spagnolo, et al.. (2020). Healthcare resource use and related costs in patients receiving nintedanib or pirfenidone for idiopathic pulmonary fibrosis. Epidemiology. 1673–1673. 1 indexed citations

Gallagher, Christopher, Tripthi Kamath, Anthony Masaquel, et al.. (2016). Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer. Breast Cancer Research and Treatment. 157(1). 145–156. 16 indexed citations

Gallagher, Christopher, Anthony Masaquel, Tripthi Kamath, et al.. (2016). Survival in patients with non-metastatic breast cancer treated with adjuvant trastuzumab in clinical practice. SpringerPlus. 5(1). 9 indexed citations

Hansen, Ryan N., Scott D. Ramsey, Deepa Lalla, et al.. (2014). Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens. SpringerPlus. 3(1). 259–259. 24 indexed citations

Bergman, Martin, Eric P. Elkin, Sarika Ogale, Tripthi Kamath, & Max Hamburger. (2014). Response to Biologic Disease-Modifying Anti-Rheumatic Drugs after Discontinuation of Anti-Tumor Necrosis Factor Alpha Agents for Rheumatoid Arthritis. Rheumatology and Therapy. 1(1). 21–30. 9 indexed citations

Babigumira, Joseph B., Vincent Antao, Bruce Wang, et al.. (2014). Projecting the cost-effectiveness of pertuzumab with trastuzumab and docetaxel in the neoadjuvant treatment of HER2-positive, locally advanced, inflammatory or early breast cancer.. Journal of Clinical Oncology. 32(15_suppl). 642–642. 4 indexed citations

10.

Gallagher, Christopher, Anthony Masaquel, Tripthi Kamath, et al.. (2014). Relapse impact on overall survival in trastuzumab-treated women with HER2+ early-stage breast cancer.. Journal of Clinical Oncology. 32(15_suppl). e11601–e11601. 1 indexed citations

11.

Mayer, Musa, Matthew Sussman, Anthony Masaquel, et al.. (2014). Individual attributions of living longer with HER2+ metastatic breast cancer: Findings from a community web-based survey.. Journal of Clinical Oncology. 32(30_suppl). 197–197. 1 indexed citations

12.

Szefler, Stanley J., Robert S. Zeiger, Tmirah Haselkorn, et al.. (2011). Economic burden of impairment in children with severe or difficult-to-treat asthma. Annals of Allergy Asthma & Immunology. 107(2). 110–119.e1. 78 indexed citations

13.

Broder, Michael S., et al.. (2009). Adherence and persistence with omalizumab and fluticasone/salmeterol within a managed care population. Allergy and Asthma Proceedings. 30(2). 148–157. 22 indexed citations

14.

Chen, Hubert, Michael K. Gould, Paul D. Blanc, et al.. (2007). Asthma control, severity, and quality of life: Quantifying the effect of uncontrolled disease. Journal of Allergy and Clinical Immunology. 120(2). 396–402. 187 indexed citations

15.

Ramsey, Scott D., Lauren Clarke, Tripthi Kamath, & Deborah P. Lubeck. (2006). Evaluation of Erlotinib in Advanced Non-Small Cell Lung Cancer: Impact on the Budget of a U.S. Health Insurance Plan. Journal of Managed Care Pharmacy. 12(6). 472–478. 36 indexed citations

16.

Chen, Hubert, Paul D. Blanc, Tripthi Kamath, June H. Lee, & Sean D. Sullivan. (2006). ASSESSING THE IMPACT OF ASTHMA CONTROL ON QUALITY OF LIFE IN PATIENTS WITH SEVERE OR DIFFICULT-TO-TREAT ASTHMA. CHEST Journal. 130(4). 95S–95S. 1 indexed citations

17.

Joffres, Michel R., et al.. (2004). Impact of guidelines on health care use for the management of dyslipidemia in two Canadian provinces, Alberta and Nova Scotia, from 1990 to 2001.. PubMed. 20(8). 767–72. 7 indexed citations

18.

Malik, Shaista, Nathan D. Wong, Stanley S. Franklin, et al.. (2004). Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults. Circulation. 110(10). 1245–1250. 1443 indexed citations breakdown →

19.

Wong, Nathan D., Jose R. Pio, Stanley S. Franklin, et al.. (2003). Preventing coronary events by control of lipids and blood pressure in persons with the metabolic syndrome. Journal of the American College of Cardiology. 41(6). 268–268. 2 indexed citations

20.

Wong, Nathan D., Jose R. Pio, Stanley S. Franklin, et al.. (2003). Preventing coronary events by optimal control of blood pressure and lipids in patients with the metabolic syndrome. The American Journal of Cardiology. 91(12). 1421–1426. 113 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact